Correlation between contrast-enhanced Doppler US and Lipiodol CT in hepatocellular carcinoma treated with chemoembolization;Correlazione tra ecografia Doppler con mdc e TC nello studio dell'epatocarcinoma sottoposto a chemioembolizzazione

Radiologia Medica

Volumn 95, Issue 6, 1998, Pages 608-613

  Catalano, Orlando ^a,b   Cusati, Bianca ^a   Esposito, Maria ^a   Trivellini, Vittorio ^a   Lobianco, Roberto ^a   Siani, Alfredo ^a  

^a Ospedale S Maria delle Grazie   (Italy)

^b NONE   (Italy)

Author keywords

HCC chemoembolization; HCC, contrast enhanced Doppler US; HCC, Lipiodol CT; Liver, HCC

Indexed keywords

IODINATED POPPYSEED OIL; SHU 508;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; EVALUATION STUDIES; FEMALE; HUMANS; IODIZED OIL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYSACCHARIDES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 0031771505     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Angeli E, Carpanelli R, Crespi G e Coll: Efficacia del SH U 508 A (Levovist) nella valutazione con color-Doppier della vascolarizzazione dell'epatocarcinoma Radiol Med 87 (Suppl. 1 al n. 5): 24-31, 1994.
2. Bartolozzi C, Lencioni R, Caramella D e Coll: Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 191: 123-128, 1994.
3. Bartolozzi C, Lencioni R, Caramella D e Coll: Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197: 812-818, 1995.
4. Bartolozzi C, Lencioni R, Armillotta N: Trattamento combinato dell'epatocarcinoma con chemioembolizzazione e alcolizzazione. Risultati a lungo termine. Radiol Med 94: 19-23, 1997.
5. Basilico R, Filippone A, Muzi M e Coll Valutazione dell'efficacia terapeutica dell'alcolizzazione nell'epatocarcinoma: confronto tra Tomografia Computerizzata ed eco color Doppler. Radiol Med 92: 92-96, 1996.
6. Becker D, Gunther E, Hahn EG e Coll: Imaging tumor vasculanzation of hepatocelluar carcinoma with ultrasound angiography Ultraschall Med 16: 109-112, 1995
7. Campani R, Bozzini A, Calliada F e Coll. Impiego di un mezzo di contrasto per ecografia SH U 508 A (Levovist) Schering nello studio delle metastasi epatiche con color-Doppler. Radiol Med 87 (suppl. 1 al n. 5) 32-40, 1994.
8. Campani R, Calliada F, Bottinelli O e Coll: Clinical usefulness of color Doppler enhancement in the assessment of the liver and the portal system. In. Nanda NC, Schlief R, Goldberg BB (eds) Advances in echo imaging using contrast enhancement, pag 561-583 (II edizione), Kluwer Academic Publishers, Dubai, 1997.
9. Choi BI, Shin YM, Ilan JK e Coll: Focal hepatic nodules after transcatheter oily chemoembolization, detection with spiral CT versus conventional CT. Abdom Imaging 21: 33-36, 1996.
10. Choi BI, Kim TK, Han JK e Coll. Power versus conventional color Doppler sonography. comparison in the depiction of vasculature in liver tumors Radiology 200: 55-58, 1996.
11. Choi BI, Lee HJ, Han JK e Coll: Detection of hypervascular nodular hepatocellular carcinomas, value of triphasic helical CT compared with iodized-oil CT. AJR 168: 219-224, 1997.
12. Choi BI, Kim HC, Han JK e Coll: Therapeutic effects of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182: 709-713, 1992.
13. Dalla Palma L, Pozzi Mucelli R, Sponza M e Coll: Valutazione comparativa dell'ecografia, della Tomografia Computerizzata, dell'angiografia, della Lipiodol TC nel bilancio di estensione dell'epatocarcinoma Studio multicentrico. Radiol Med 89. 270-277, 1995.
14. Dalla Palma L, Pozzi Mucelli R, Sponza M e Coll: La diagnostica mediante immagini e la terapia interventistica dell'epatocarcinoma. Studio multicentrico su 290 casi. Radiol Med 94: 30-36, 1997
15. Derchi LE, Rizzatto G, Solbiati L. I mezzi di contrasto nell'ecografia. Radiol Med 84: 208-215, 1992
16. De Santis M, Romagnoli R, Cristani A e Coll: MRI of small hepatocarcinoma: comparison with US, CT, DSA and Lipiodol CT JCAT 16: 189-197, 1992.
17. Ernst H, Hahn EG, Balzer T e Coll: Color Doppler ultrasound of liver lesions, signal enhancement after intravenous injection of the ultrasound contrast agent Levovist J Clin Ultrasound 24: 31-35, 1996.
18. Feltrin GP, Savastano S, Marangon A e Coll: Risultati a lungo termine della chemioembolizzazione nell'epatocarcinoma Radiol Med 94. 24-29, 1997.
19. Florio F, Nardella M, Balzano S e Coll: Epatocarcinoma primitivo Diagnostica per immagim e chemioembolizzazione. Radiol Med 86: 478-483, 1993.
20. Fritzsch T, Hilmann J, Kanpfe M e coll: SH U 508, a transpulmonary echocontrast agent: initial experience Invest Radiol 25: 160-161, 1990.
21. Fntzsch T, Schlief R. Levovist. SH U-508-A. Drugs Fut 20: 1224-1227, 1995.
22. Fujimoto M, Moriyasu F, Nishikawa K e Coll: Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR 163: 1099-1104, 1994
23. Gattoni F, Dova S, Volterrani F e Coll. La Tomografia Computerizzata con Lipiodol nella valutazione del carcinoma epatocellulare. Radiol Med 89. 809-812, 1995.
24. Goldberg BB, Liu JB, Burn PN e Coll. Galactose-based intravenous sonographic contrast agent. Experimental studies J Ultrasound Med 12: 463-470, 1993
25. Hatanaka Y, Yamashita Y, Takahashi M e Coll: Unresectable hepatocellular carcinoma, analysis of prognostic factors in transcatheter management Radiology 195: 747-752, 1995.
26. Hsu HC, Wei TC, Tsang YM e Coll: Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 57: 1184-1188, 1986
27. Hwang GJ, Kim M-J, Yoo HS e Coll Nodular hepatocellular carcinomas detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 202: 383-388, 1997.
28. Ikeda N, Kumada H, Sattoh S e Coll: Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional model. Cancer 68: 2150-2154, 1991.
29. Itai Y: Lipiodol-CT for hepatocellular carcinoma. Abdom Imaging 22: 259-260, 1997.
30. Jaeger HJ, Mehring U-M, Castaneda F e Coll: Sequential transarterial chemoembolization for unresectable advanced hepalocellular carcinoma Cardiovasc Intervent Radiol 19: 388-396, 1996
31. Lencioni R, Caramella D, Bartolozzi C: Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 194: 113-118, 1995
32. Lencioni R, Pinto F, Armillotta N e Coll Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol-CT: imaging-pathologic correlation Abdom Imaging 22: 253-258, 1997.
33. Lencioni R, Pinto F, Armillotta N e Coll: Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US Radiology 201: 353-358, 1996.
34. Maresca G, Barbaro B, Summana V e Coll: Efficacia del SH U 508 A (Levovist) nella diagnosi differenziale con eco-color-Doppler delle lesioni focali epatiche. Radiol Med 87 (suppl. 1 n. 5): 41-49, 1994.
35. Maki S, Komo T, Maeda H. Image enhancement in Computed Tomography for sensitive diagnosis of liver cancer and semiquantilation of tumour selective drug targeting with oily contrast Cancer 56: 751-757, 1985.
36. Mondazzi L, Bottelli R, Brambilla G e Coll: Transartenal oily chemoembolization for the treatment of hepatocellular carcinoma a multivariate analysis of prognostic factors. Hepatology 19: 1115-1123, 1994.
37. Nakao N, Uchida H, Kamino K e Coll: Determination of the optimum dose level of Lipiodol transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol 17 76-80, 1994.
38. Oliver III JH, Baron RL Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls Radiology 201 1-14, 1996.
39. Pozzi-Mucelli R, Pozzi-Mucelli R, Pagnan L e Coll. Angiografia digitale e Tomografia Computerizzata con Lipiodol nell'inquadramento anatomopatologico dell'epatocarcinoma. Radiol Med 88: 798-805, 1994
40. Rossi C, Isceri S, Pagliacci M e Coll La chemioembolizzazione dell'epatocarcinoma Sei anni di esperienza. Radiol Med 89: 835-840, 1995.
41. Rossi P, Maccioni F, Iacobelli D e Coll: Sopravvivenza a lungo termine dei pazienti affetti da epatocarcinoma non resecabite e trattati con procedure di radiologia interventistica. Radiol Med 90. 766-771, 1995
42. Savastano S, Benvegnu L, Feltrin GP e Coll Transcatheter arterial embolization versus no treatment in cirrhotic patients with hepatocellular carcinoma. A retrospective comparative study Eur Radiol 4: 155-160, 1994.
43. Tanaka S, Kitamra T, Yoshioka F e Coll: Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply local hepatocellular carcinoma Ultrasound Med Biol 21: 157-160, 1995
44. Tanaka K, Inoue S, Numata K e Coll Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization AJR 158: 541-546, 1992.
45. Tano S, Ueno N, Tomiyama T e Coll Possibility of differentiating small hyperechoic liver tumours using contrastenhanced colour Doppler ultrasonography: a preliminary study. Clin Radiol 52: 41-45, 1997.
46. Taourel PG, Pageaux GP, Coste V e Coll: Small hepatocellular carcinoma in patients undergoing liver transplantation: detection with CT after injection of iodized oil. Radiology 197: 377-380, 1995.
47. Ukida H, Matsuo N, Nishimine K e Coll: Transcatheter arterial embolization for hepatoma with lipiodol. Semin Intervent Radiol 10. 19-26, 1993.
48. Valls C, Figueras J, Jaurrieta E e Coll: Hepatocellular carcinoma: iodized-oil CT TNM classification. AJR 167: 477-481, 1996
49. Valls C, Pamies JJ, Sancho C e Coll: Computed Tomography after lipiodol chemoembolizalion in hepatocellular carcinoma. Eur Radiol 4: 238-242. 1994
50. Vogl TJ. Trapp M, Pegios W e Coll: Volumetrische und morphologische CT-Parameter zur Prognoseabschatzung und Therapiekontrolle des hepatozellularen Karzinoms unter arterieller Chemoembolisation. ROFO 167: 219-226, 1997.
51. Yamashita Y, Mitsuzaki K, Yi T e Coll: Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR Imaging and helical CT of the whole liver. Radiology 200: 79-84, 1996.
52. Yoshimatsu S, Inoue Y, Ibukuro K e Coll: Hypovascular hepatocellular carcinoma undetected at angiography and CT with iodized oil. Radiology 171. 343-347, 1989.